AVN 66.45 Increased By ▲ 0.75 (1.14%)
BAFL 30.07 Increased By ▲ 1.08 (3.73%)
BOP 4.75 Increased By ▲ 0.16 (3.49%)
CNERGY 4.02 Increased By ▲ 0.27 (7.2%)
DFML 14.29 Increased By ▲ 0.03 (0.21%)
DGKC 43.98 Increased By ▲ 1.28 (3%)
EPCL 44.48 Increased By ▲ 2.31 (5.48%)
FCCL 11.95 Increased By ▲ 0.75 (6.7%)
FFL 4.98 Decreased By ▼ -0.06 (-1.19%)
FLYNG 6.14 Increased By ▲ 0.31 (5.32%)
GGL 10.41 Increased By ▲ 0.16 (1.56%)
HUBC 62.09 Increased By ▲ 1.94 (3.23%)
HUMNL 5.87 Increased By ▲ 0.13 (2.26%)
KAPCO 27.51 Increased By ▲ 0.62 (2.31%)
KEL 2.22 Decreased By ▼ -0.02 (-0.89%)
LOTCHEM 26.73 Increased By ▲ 0.55 (2.1%)
MLCF 22.52 Increased By ▲ 1.53 (7.29%)
NETSOL 86.60 Increased By ▲ 1.98 (2.34%)
OGDC 86.30 Increased By ▲ 0.40 (0.47%)
PAEL 11.38 Increased By ▲ 0.23 (2.06%)
PIBTL 4.29 No Change ▼ 0.00 (0%)
PPL 80.26 Decreased By ▼ -0.04 (-0.05%)
PRL 13.66 Increased By ▲ 0.98 (7.73%)
SILK 0.90 Decreased By ▼ -0.01 (-1.1%)
SNGP 41.92 Increased By ▲ 0.62 (1.5%)
TELE 6.29 Increased By ▲ 0.24 (3.97%)
TPLP 16.39 Increased By ▲ 0.52 (3.28%)
TRG 112.91 Increased By ▲ 2.41 (2.18%)
UNITY 14.42 Increased By ▲ 0.49 (3.52%)
WTL 1.20 Increased By ▲ 0.02 (1.69%)
BR100 4,075 Increased By 124 (3.14%)
BR30 14,525 Increased By 302.7 (2.13%)
KSE100 40,847 Increased By 1061.6 (2.67%)
KSE30 15,212 Increased By 411.4 (2.78%)
Follow us

The pharmaceutical industry has come to an agreement with the government over revised prices of paracetamol products, and also initiated production of the medicine, according to an official statement by the finance ministry on Wednesday.

The development comes after Federal Minister for Finance and Revenue Ishaq Dar held a meeting with heads of major pharmaceutical companies to discuss the retail price of paracetamol products, said the Ministry of Finance.

“The pharma industry agreed upon the reduced prices of paracetamol 500mg tablet at Rs2.35, paracetamol extra 500 mg at Rs2.75 and syrup at Rs117.6, which is almost half the price increase demanded by them,” read the statement.

Moreover, the production of paracetamol products has been initiated, added the statement.

The development comes days after GlaxoSmithKline Consumer Healthcare (GSKCH) declared force majeure regarding the production of Panadol Tablets (or generic paracetamol), Panadol Extra Tablets and Children’s Panadol Liquid Range.

In a filing to the Pakistan Stock Exchange (PSX) on Friday, the company had said that it sent “several letters to various government stakeholders regarding the critical issue of extraordinary and rapid increase in paracetamol (raw material) prices in Pakistan.”

But, according to media reports, the same was rejected after a prolonged delay by the latter without any intimation of reason(s) given to the company.“

The prices of medicines in Pakistan are regulated by the Drug Regulatory Authority of Pakistan (DRAP), which means pharmaceutical companies cannot increase rates unless the authority gives them a go-ahead.

Talking to Business Recorder, Dr Kaiser Waheed, former chairman of the Pakistan Pharmaceutical Manufacturers’ Association (PPMA), the representative body of pharma companies, said that the agreement was reached between the government and GSKCH, not the “entire pharma industry”.

Waheed said the pharmaceutical industry was in talks with the government to provide subsidies to the sector. “However, the government said that it cannot afford to give any subsidy,” he added.

Last month, the PPMA warned that it will increase the prices of select medicines if the DRAP does not hold talks by Monday, October 3.


Comments are closed.

Pharma firms to resume production of paracetamol after meeting with Dar: Ministry of Finance

Alarm bells: SBP-held foreign exchange reserves plunge $923mn, now stand at mere $3.7bn

Imran Khan's arrest will create instability in country: President Alvi

Rupee plunges to record low in inter-bank market after nearly 10% fall

After Fawad's arrest, Imran says state cannot 'terrify us into submission'

KSE-100 increases over 1,000 points as Pakistan moves to revive IMF programme

14-member KP caretaker cabinet takes oath

PM Shehbaz reaffirms resolve to deepen economic, trade engagement with US

Pakistan to decide currency for Russia oil trade in March: Musadik Malik

Pakistan reviewing India’s Shanghai Cooperation Organisation invite: FO

Ishaq Dar has inflicted huge financial dent to Pakistan: Miftah Ismail